Press Releases Relief Therapeutics Holding SA

Equities

RLF

CH1251125998

End-of-day quote Swiss Exchange Other stock markets 03:30:00 06/05/2024 am IST			5-day change	1st Jan Change
1.28 ^CHF	+9.87%		-1.54%	-35.68%

30/04	Relief Therapeutics Holding SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI
30/04	Relief Therapeutics' FY23 Loss Widens; Revenue Edges Down	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

RELIEF THERAPEUTICS Holding SA to Hold Extraordinary General Meeting	28/03	AQ
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria	22/03	AQ
Relief Therapeutics Shifts Commercial Operations to Partnership Model, Focusing on Efficient Patient Access and R&D Growth	06/12	AQ
Relief Therapeutics Announces CEO Transition	23/11	AQ
Relief Therapeutics announces that more than 400,000 of its ADRs are currently outstanding and that, as a result, the Company has achieved an Important NASDAQ Initial Listing Milestone	11/23/11	AQ
Relief Therapeutics Reports Half-Year 2023 Financial Results and Provides Corporate Update	18/23/18	AQ
RELIEF THERAPEUTICS Holding SA Announces CHF 5 Million Private Placement	19/23/19	AQ
Relief Therapeutics Announces Implementation Timeline for Reverse Split of Ordinary Shares	03/23/03	EQ
Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA™ Commercial Launch Progressing Ahead of Schedule	01/23/01	EQ
Relief Therapeutics Announces Results of Extraordinary General Meeting of Shareholders	28/23/28	EQ
Relief Therapeutics Announces Positive 12-Month Stability Data for Inhaled and Intravenous Preparations of RLF-100	17/23/17	EQ
Relief Therapeutics Announces Full Year 2022 Financial Results and Provides Corporate Update	14/23/14	EQ
Relief Therapeutics Announces Executive Leadership Team Change	05/23/05	EQ
Relief Therapeutics Holding SA to Hold Extraordinary General Meeting of Shareholders	04/23/04	EQ
Relief Therapeutics Appoints World-Renowned Gene Therapy Pioneer Guangping Gao, Ph.D. as Chair of Scientific Advisory Board	03/23/03	EQ
Relief Therapeutics Announces Survey Results Identifying Preferred Urea Cycle Disorder Treatment Attributes Presented by Collaboration Partner at SIMD 2023	22/23/22	EQ
Relief Therapeutics to Present Pre-Clinical Evidence for Improved Amino Acid Utilization with PKU GOLIKE at the Society for Inherited Metabolic Disorders 44th Annual Meeting	18/23/18	EQ
Relief Therapeutics Announces Availability of New PKU GOLIKE BARs in Europe	16/23/16	EQ
Relief Therapeutics Provides Update From Collaboration Partner on OLPRUVA™	15/23/15	EQ
Relief Therapeutics Recognizes Rare Disease Day and Announces U.S. Availability of New PKU GOLIKE Bars	28/23/28	EQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Relief Therapeutics Holding SA

Equities

RLF

CH1251125998

Press Releases

Filters